As of 2026-09-24, the Intrinsic Value of Dyne Therapeutics Inc (DYN) is -13.91 USD. This DYN valuation is based on the model Peter Lynch Fair Value. With the current market price of 16.23 USD, the upside of Dyne Therapeutics Inc is -185.68%.
Based on its market price of 16.23 USD and our intrinsic valuation, Dyne Therapeutics Inc (DYN) is overvalued by 185.68%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -13.91 - -13.91 | -13.91 | -185.68% |
| P/E | (53.96) - (69.81) | (59.59) | -467.2% |
| DDM - Stable | (24.47) - (74.59) | (49.53) | -405.2% |
| DDM - Multi | (1.34) - (3.13) | (1.87) | -111.5% |
| Market Cap (mil) | 3,030.95 |
| Beta | 1.06 |
| Outstanding shares (mil) | 186.75 |
| Enterprise Value (mil) | 2,568.32 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.66% |
| Cost of Debt | 5.00% |
| WACC | 9.47% |